• Follow the Money: Inflammatory Bowel Disease Oral Drug, Breast, Colorectal Cancer ADCs, Other Next-Gen, Novel Treatments

    Bio-IT World | NewLimit plans to launch its first human clinical trial next year, testing a liver cell-reprogramming therapy; SonoThera advances its lead programs in Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into the clinic; Portal’s platform uses mechanoporation to deliver materials such as RNA, gene editors, probes, and antibodies; and more.

    Jul 1, 2026

  • Anthropic Launches Claude Science, Illumina's Spatial Insights Tool, Wellcome Sanger Institute, Google DeepMind AI Consortium

    Bio-IT World | Hartwig Medical Foundation and Ultima Genomics expand their strategic collaboration; Thermo Fisher launches its Invitrogen E-Gel Power Snap Lite Electrophoresis System; the Pistoia Alliance announces the next phase of its Identification of Medicinal Products Ontology; and more.

    Jun 30, 2026

  • The Spatial Biology Bottleneck: Why AI Models Fail on Complex Tissue & What Actually Fixes It

    Bio-IT World | The life sciences industry has spent years optimizing AI architectures for cell segmentation and generating benchmark comparisons that demonstrate impressive performance on clean, standardized tissues. Yet far less energy has gone into the one question that actually determines whether a model can handle unique morphology: does the training data reflect the structural complexity the model will encounter in the real world?

    Jun 26, 2026

  • Every Microbiome Tells a Changeable, Computable Story

    Bio-IT World | People are not only human but also microbial, a summation largely of the choices they make: their social interactions, the food they eat, medications they take, their activity level, and daily habits. The microbes that are transmissible person-to-person are sometimes beneficial, but the odds are slightly better that they are causing harm.

    Jun 24, 2026

  • Notes from the Trenches: A Computational Biologist’s View of Drug Discovery’s Digital Revolution

    Bio-IT World | When Eleanor Howe took the stage at Bio-IT World Conference & Expo 2026 to deliver the annual “Trends from the Trenches” address, she arrived with a clear mandate: no buzzwords, no vendor spin, and no marketing varnish. She built this year’s Trends from the Trenches session from hours of interviews with colleagues, clients, and trusted advisors across the life sciences sector, delivering a wide-ranging, candid survey of where the field actually stands and what she predicts lies ahead.

    Jun 23, 2026

  • AI Readiness in Pharma – Getting the Foundation Right

    Bio-IT World | Many years ago, when AI was seen more in science fiction than in the real world, we were asked a seemingly simple question in an innovation workshop – why is it that our bank accounts and credit cards can be used globally, but we can’t do the same with our health information?

    Jun 18, 2026

  • AI Readiness in Pharma – Getting the Foundation Right

    Bio-IT World | Many years ago, when AI was seen more in science fiction than in the real world, we were asked a seemingly simple question in an innovation workshop – why is it that our bank accounts and credit cards can be used globally, but we can’t do the same with our health information?

    Jun 18, 2026

  • The Invisible Infrastructure: Bio-IT World Panel Warns of a Slow-Motion Crisis in Biomedical Data

    Bio-IT World | A group of researchers is sounding the alarm: the publicly funded data infrastructure underpinning virtually all of modern biomedical research is fragile, underfunded, and increasingly at risk. It is up to us to safeguard it. At a session at last month’s Bio-IT World Conference & Expo, Douaa Mugahid, PhD, Data Officer at the Hi-IMPAcTB Consortium at the Harvard School of Public Health moderated a panel of academics, investors, and consultants to take on the future of public data and software infrastructure.

    Jun 17, 2026

  • Microsoft, Ginkgo Collaborate to Demonstrate Lab-in-the-Loop Biology

    Bio-IT World | Earlier this month at Microsoft Build 2026, Microsoft announced general availability of Microsoft Discovery, a platform designed to support the iterative testing cycles inherent in research and discovery workflows by helping build and govern agentic AI workflows across scientific and engineering disciplines, supporting the iterative loops, evidence preservation, and tool coordination that define scientific work.

    Jun 15, 2026

  • From Automation to Autonomy: How Agentic AI Is Redefining Biopharma’s Digital Workforce

    Bio-IT World | Biopharma’s relationship with automation has historically been pragmatic and incremental. Robotic process automation, rules‑based workflows, and task‑specific machine‑learning models have been widely deployed to reduce manual effort and accelerate well‑defined tasks. These approaches delivered value, but they remained fundamentally limited: each tool addressed a narrow slice of work, often creating additional handoffs between systems and teams.

    Jun 12, 2026

  • Navigating the Perilous Journey from Lab to Market

    Bio-IT World | The translation of promising lab ideas into commercial impact is fraught with multiple valleys of death, beginning with the technical, funding, and people challenges of getting medical interventions out of academia and into clinical trials in the first place.

    Jun 10, 2026

  • As AI Reshapes Drug Discovery the Lab Remains the Bottleneck

    Bio-IT World | At a plenary session at the Bio-IT World Conference & Expo last month, Jeremy Jenkins, a computational drug discovery leader at Novartis, delivered a frank and wide-ranging assessment of where artificial intelligence is genuinely accelerating pharmaceutical R&D — and where it keeps running into the same old wall: biology.

    Jun 9, 2026

  • Federation Plus Fine Tuning: The Push for Federated Learning Models Continues

    Bio-IT World | Federated learning is changing the rules in drug discovery, argued a group of speakers at last month’s Bio-IT World Conference & Expo. The opportunities are robust, but success depends on establishing trust and fine-tuning models for individual applications.

    Jun 4, 2026

  • Trends from the Trenches: AI-Ready Life Sciences Data

    Bio-IT World | In the latest episode of Trends from the Trenches, Adam Marko, CTO of Life Science Field at Hammerspace, speaks with host Jessica StLouis about AI-ready data as a practical outcome. Researchers see one familiar file system, while the platform handles where data lives, how it moves, and who can access it. That shift reduces “data friction,” allowing scientists to spend less time hunting files and more time conducting research.

    Jun 3, 2026

  • A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs

    Bio-IT World | VeriSIM Life is building the “full-stack predictive infrastructure” to help pharma companies foresee the challenges ahead in translating a molecule from laboratory discovery to a successful human therapy. The help comes in the form of a dynamic, “credit-score-like” assessment of the risk with inherent explainability and trust.

    Jun 2, 2026

  • Immunai, AstraZeneca Expand Partnership, Rancho Biosciences Releases Multi-omics Datasets, Dotmatics AI Co-Scientist

    Bio-IT World | Reimagine Care expands its AI-enabled virtual oncology care program with Moffitt Cancer Center; Verana Health continues rapid expansion of its ovarian cancer database; SandboxAQ integrates its Large Quantitative Models with Claude; and more.

    May 29, 2026

  • Insilico Medicine, Human Longevity Partner for Longevity Foundation Model

    Bio-IT World | Insilico Medicine and a Human Longevity spinout announced a strategic collaboration yesterday to develop large-scale foundation models for human longevity science capable of predicting disease risk, understanding aging biology, and accelerating the development of preventive and therapeutic interventions to extend healthy human lifespan.

    May 28, 2026

  • Bio-IT World VIP Conference: Exploring Breadth vs. Depth

    Bio-IT World | At the 3rd annual Bio-IT World Venture, Innovation, & Partnering Conference on May 19, AI stole the show—but beneath all the talk of large language models (LLMs) and AI agents, a throughline emerged that was on most speaker’s minds: the choice between breadth and depth.

    May 27, 2026

  • Follow the Money: AI Drug Design Engine, Treating Multiple Myeloma, Quantum Healthcare Platform

    Bio-IT World | Isomorphic Labs continues development and deployment of its AI drug design engine; CellCentric advances in multiple myeloma; NVision combines quantum computing for drug design with the company’s POLARIS platform; and more.

    May 26, 2026

  • At Bio-IT World's 25th Anniversary, Rare Disease Takes Center Stage

    Bio-IT World | In the opening plenary session at the 25th annual Bio-IT World Conference & Expo on Tuesday, we hosted an intimate series of paired conversations, each designed to place a different set of puzzle pieces on the table, examining that puzzle from four distinct vantage points — patient experience, AI-assisted diagnostics, venture investment, and policy reform — with each conversation delivering a bit more clarity to the emerging picture.

    May 22, 2026